SCHEMBL5227550

SCHEMBL5227550

ONC(=S)C1=CC=CCC1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9247348 0.82
SCHEMBL17844294 0.75 TAS2R38 (0.43)
SCHEMBL4739774 0.75
SCHEMBL3080784 0.75
SCHEMBL2106683 0.73
SCHEMBL238092 0.73
SCHEMBL11327636 0.73
SCHEMBL4740303 0.73 ALDH1A1 (0.35)
SCHEMBL182009 0.72
SCHEMBL4738754 0.71 KMT2A (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1262181-B1 USE OF ISOTHIAZOLE DERIVATIVES AS UREASE INHIBITORS FOR THE TREATMENT OF HELICOBACTER PYLORI INDUCED GASTROINTESTINAL DISEASES OTSUKA PHARMA CO LTD (JP) 2007-05-16 EP disclosed
US-20040058952-A1 Urease inhibitors OTSUKA PHARMACEUTICAL CO., LTD. 2004-03-25 US disclosed
US-20030060482-A1 Urease inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2003-03-27 US disclosed
EP-1262181-A1 UREASE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-12-04 EP disclosed